Research And DevelopmentDirectory > Business > Biotechnology_and_Pharmaceuticals > Pharmaceuticals > Research and Development
| |||||||||||||||
  Genentech's mission is to develop drugs to address significant unmet medical needs. Genentech manufactures and markets seven products that help save or improve lives every day. |
Global specialty pharmaceutical company focusing on central nervous system (CNS), gastrointestinal (GI), and renal diseases. Based in Chineham, England. (Nasdaq: SHPGY) |
Research-based, global pharmaceutical company responsible for the discovery and development of medicines. |
Biopharmaceutical company focused on the development of therapeutic and diagnostic products using genomic and proteomic technologies. Services include drug discovery, gene discovery and genetic testing. |
Discovers, develops, manufactures and sells pharmaceutical and nutritional products such as drug delivery systems, antibiotics and prepared infant formulas. Includes investor an investor relations area, and a career center. (NYSE: ABT). |
A biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for viral diseases, infectious diseases and cancer. It has research, development and manufacturing facilities in the U.S., and marketing organizations in Europe and Australia. |
Develops ribozyme-based pharmaceuticals applicable to a wide range of human diseases. [Nasdaq: RNAI] |
Provider of products and services that accelerate drug discovery and chemical development. |
Provides pharmacology, lead discovery, HTS, metabolism, drug discovery, drug development, safety pharmacology, biotechnology, and biosafety contract research services. |
Early stage pharmaceutical company specializing in targeted delivery of therapeutic compounds to specific immune cells as cost-effective therapy for inflammatory and autoimmune diseases. |
MDL is a leading provider of integrated logistics and decision support systems that enable a high-throughput environment for research and development in the life sciences and chemical industries. |
Custom research organization specializing in synthesis of organic compounds, process and drug development and GMP manufacturing of pharmaceuticals and fine organic chemicals. |
Development and marketing of medications used in the fields of neurology, dermatology and infectious diseases. Includes corporate and production details. Headquarters in Aliso Viejo, California, USA. |
Contract drug discovery and development company, in Shenzhen, China. |
Development and distribution of products for the treatment of major diseases, with company profile and research details. Milan, Italy. |
A leading provider of integrated drug discovery services to the Pharmaceutical and Biotechnology sectors. |
EUCRO - aims to supply companies with new product opportunities through own product development or co-development, globalisation of licences and trading of health care products. |
Pharmaceutical company which uses its diverse technology platform to discover and develop novel medicines for healthcare. |
Pharmaceutical company specialised in photodynamic therapy (PDT). Destiny has a custom research service specialised in formulations, in phospholipids, liposomes and other solubilisation and suspension systems. |
Biopharmaceutical research and development of treatments for migraine, obesity, sexual disfunction and Parkinson disease. |
The Leeds centre brings together more than 40 experts in biochemistry, chemistry, physics, biomedical science and clinical medicine to develop the new technology known as 'Photodynamics'. |
Developing products that: 1) Protect humans against the debilitating side effects of cancer chemotherapy and radiotherapy, and 2) Protect animals and humans against lethal gastrointestinal pathogens and carcinogens. |
Pharmaceutical company engaged in the discovery, development, and commercialization of leading-edge technology in the areas of oncology and dermatology. |
RxIBR is bringing innovations, Targeted Biologic Therapy from the Institute of Biologic Research into commercial fruition. |
Developing therapies for neurological disorders such as spinal cord injuries, neurodegenerative diseases and glaucoma. Features explanation of technology and details of clinical studies. Los Angeles, California, USA. |
A pharmaceutical company focusing on discovery and development of drugs for cancer and women's health. |
Commercial contract research organization (CRO) providing low cost pre-clinical drug development services to biopharmaceutical companies (pharmicological screening and acute toxicology). |
Biopharmaceutical company located in Atlanta, Georgia. It is a subsidiary of Dr. Reddy's Group, Hyderabad, India. Our research focus is on discovering novel therapeutics that address unmet medical needs in diabetes, inflammation, lipid metabolism, oncology and cardiovascular disease. |
Biomedical pharmaceutical company working on new treatments for Crohn's Disease. |
Leader in the biopharmaceutical drug delivery field, with technology of apply its polymer coupling technology platforms and advanced analytical methods. |
Discovering, developing and commercializing new therapeutic agents. |
A division of the Department of Pharmceutics at Rutgers University which conducts preclinical studies in absorption, metabolism, distribution, and excretion (ADME) assessment of new chemical entities and of existing drug compounds incorporated into drug delivery vehicles. |
A research and development company offering analytical, preformulation, formulation and stability testing services to the pharmaceutical and biotechnology industries. |
Specializes in pharmaceutical research, development and manufacturing of diabetes treatment drug DIAB II, also known as Sucanon, a new drug for the treatment of type 2 diabetes |
Research-based biopharmaceutical company seeking to discover and develop new healthcare solutions to treat and diagnose crucial unmet medical conditions in the neurological and oncological sectors. Padua, Italy. |
Develops small-molecule drugs for treatment of immunological, viral, and cardiovascular diseases and disorders, using structure-based drug design. Includes programs, trials and investors' profile, with headquarters in Birmingham, Alabama. (Nasdaq: BCRX) |
A high quality research, development and testing laboratories offering a broad range of services to all phases of the pharmaceutical industry from early drug development through commercial manufacturing. |
A biopharmaceutical company discovering and developing new drugs to fight cancer. |
Develops novel metalloporphyrin therapeutics for the treatment of cancer and neurodegenerative diseases. Includes clinical trail for amyotrophic lateral sclerosis, investor details, and publications from Greenwood Village, Colorado. |
Provides contract research services to pharmaceutical and biotech companies, in the areas of chemistry, formulations, pre-clinical pharmabiology, and bioanalytical studies. Based in India. |
Developing cause-oriented treatment for Parkinson's, Alzheimer's, and Lou Gehrig's diseases based on preventing mitochondrial DNA damage, the earliest recognized event in these neurodegenerative disorders, with proprietary polyamine drug, Tetramine. |
A full service contract research organization, a member of AALAS following AAALAC and NIH guidelines. We can supply all the services you need for drug development; from in vitro screening through preclinical animal studies to low cost preliminary clinical trials coordinated and performed offshore. |
The use of zwitterionic technology to treat disease. Research and development of new therapeutic modalities for cancer, immunology and infectious disease. |
Developing diagnostic technology products based on its patented software and algorithm, the PD2i Algorithm. |
Your partner for contract development and production of biopharmaceuticals. The company is primarily engaged in development, clinical testing, production and analysis of proteins for human therapeutic or diagnostic use according to international standards. |
Veterinary pharmaceutical research and development firm dedicated to solutions for fescue toxicosis and other animal problems, especially for equine. |
Antibiotic discovery, using proprietary technology as a platform, for growing previously unculturable microorganisms in the laboratory. Includes publications, related news, and careers in Cambridge, Massachusetts. |
A contract research organization providing products and research services in molecular biology, cell culture, biochemistry, and molecular histology to accelerate each client's drug discovery and preclinical development efforts. |
Research and development biotechnology company specializing in treatments for type 2 diabetes and obesity. |
Developing treatments for CNS disease. |
California based company developing, designing, and producing a complete line of diagnostics reagents and kits for use in various health care industries. |
Argenta scientists work under contract to convert hits and leads from high-throughput screening into validated patentable lead series. |
Biota is an Australian listed company, based in Melbourne and engaged in the management of research and development of human pharmaceuticals for the treatment of viral respiratory diseases. |
Develops, manufactures and markets vaccines and medications of biological origin. Includes career and investor information, and details of subsidiaries. Parkville, Victoria, Australia. |
Australian biomedical research company, which funds, manages, and commercialises diagnostic and therapeutic research projects including cancer diagnostic tests and antiviral agents. |
Guide to products and research for treatment of Alzheimers with Aricept. |
Provides services in pharmacology, in molecular biology and lead development, in toxicology, metabolism and bio-availability, in combinatorial chemistry, HTS, HTP, HTLD and computational chemistry. |
Early stage drug discovery opportunities, research expertise and facilities, and intellectual property available for licensing from the Strathclyde Institute for Drug Research, University of Strathclyde, Glasgow, Scotland. |
AME's mission is to be the world leader in directed evolution, delivering superior value to patients, employees, collaborators and stockholders by discovering, developing and commercializing optimized human biotherapeutics. |
Nanotechnology research and development of antibiotic, antitumor and custom peptides. |
Company focus on the research and development of novel pharmaceutical and functional food products based on clinical and pre-clinical data generated from medicinal plant extracts. |
Pharmaceutical company makes Remicade, new treatment for Crohn's Disease. |
Develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders. |
Developer of Microcyn 60 disinfectant, L3 oncology compound and drug-eluting stents along with other disruptive health care technologies. |
A clinical research company, located in Leonia, New Jersey, U.S.A. Specialize in providing early phase drug development services. |
Researches and develops compounds that inhibit the formation, deposition and toxic effects of amyloid fibrils within the body. |
Cytomyx provides its clients in the pharma-biotech and life-science communities with a complete range of genomic and proteomic discovery research services and reagents. |
Development of drugs for treatment of neurovascular, respiratory and allergic disorders, with career and subsidiary information, plus international contact details. |
Development stage pharmaceutical company focused on the identification of cytochrome P450 enzymes for development of drug candidates and diagnostics. Located in Kingston, Ontario, Canada. |
Quebec-based pharmaceutical company. Research on chronic and neuropathic pain based on chloride ion imbalance in the spinal cord involving Kcc2. |
A research-oriented biotechnology company gaining new insights into ORIgins of DISeases with genomic and proteomic investigation of human diseased tissues. The company will develop new diagnostic and therapeutic targets and substances. |
Pherin Pharmaceuticals is focused on the discovery and development of vomeropherins, a new family of pharmaceutical compounds for the treatment of central nervous system and neuroendocrine system disorders. |
Our mission is to optimize the therapy and prevention of disease in populations in the US and abroad through regulatory support, innovative epidemiological research, education, and product development. |
Discovers, develops, manufactures and markets isoflavonoids for menopausal non-prescription drugs, and multiple signal transduction regulator drugs for cancer. Includes technological overview, and history of company, with offices in Europe and North America, and headquarters in North Ryde, New South Wales. (Nasdaq: NVGN) |
Developing platform electroporation technology for targeted in vivo delivery of membrane limited therapeutic agents including pharmaceutical compounds and DNA-based therapies. |
An independent biopharmaceutical company engaged in the discovery and development of pharmaceuticals for the treatment of life threatening human viral diseases. |
A company focused on discovery and development of biotherapeutics for treatment of vascular diseases. |
Develops and markets new compounds including antibiotics. Features investor information and product details. Waltham, Massachusetts, USA. |
Pharmaceutical manufacturing and research company committed to providing manufacturing and scientific services to the health-care industry that meet and exceed our customer's expectation of quality, while always striving for continuous improvement. |
A player in the development of recombinant human lactoferrin (rhLF), is a biopharmaceutical company focused on developing protein-based drugs for oncology, asthma and wound healing. |
A company focused on the prediction and experimental evaluation of ADME and Pharmacokinetics for drug discovery. |
Biopharmaceutical company focused on the discovery, acquisition, development and commercialization of novel drug candidates for central nervous system, cardiovascular and urological disorders. |
Pharmaceutical CRO and PDO based in Hanover, MD with worldwide affiliate companies. |
Drug research company, developing targeted medicines for the treatment of cancer, diabetes, obesity and depression based in Australia. |
A discovery company combining scientific investigation of traditional plant-based remedies and latest scientific technology to offer novel bioactive molecules to the pharmaceutical, cosmeceutical, nutraceutical and biotechnology industries. |
Specializes in combining inhibitors of bacterial resistance with proven antibiotics to treat serious infections. Based in San Diego, California. |
Studies, publications, and news about the diagnostic drugs, synthetic human and porcine secretin. |
Advanced evaluations, treatments, monitoring, education, for those with psychiatric and neurological diseases. |
Development of techniques to focus the release of cytostatics to tumour tissue based in Uppsala, Sweden. |
Drug discovery and development company with peptide drugs to treat cancer and immune-mediated diseases. |
Fine chemicals catalog, technical reports and related resources for the life sciences and chemicals development markets. Contacts for research centers in New York, Washington and Mount Prospect, Illinois. |
Compounding and research pharmacy with a focus in drug delivery systems, primarily in the topical therapeutic application of drugs. PDL has developed several new compounds for the management of pain and nausea, especially for the terminally ill hospice patient. |
A product-focused cardiovascular drug development company based Vancouver.(Nasdaq: CRME) |
Pharmaceutical research and development company focused on developing drugs to treat diabetes, obesity and CNS disorders. |
Biopharmaceutical company focused on saving lives utilizing Samaritan Laboratories, Georgetown University's School of Medicine, to identify and design drugs for Alzheimer's, AIDS, cancer and cholesterol and process resulting "drug candidates" through the FDA to obtain approval. |
A specialty pharmaceutical company principally engaged in the development of oral, controlled release products. |
A company focuses on developing nano-scale inhaled, nasal, injectable, and oral delivery systems for improved drug therapies base Alachua, Florida |
Developing innovative therapeutic and prophylactic products that harness the power of the immune system to treat cancer, allergy, asthma and infectious diseases, and help accelerate recovery of the immune system after cancer chemotherapies. |
The new Benaroya Research Institute at Virginia Mason is a state-of-the-art facility built specifically for collaborative biomedical research. |
Discovery, manufacture and marketing of products used in oncology and endocrine therapy, with development strategies and investor information. Quebec, Quebec, Canada. [French and English] |
A medium sized research and development company located Freiburg southwest of Germany focusing on protein kinase targeted drug discovery. |
A generic pharmaceutical research and development company. |
A broadly based emerging pharmaceutical company, with a balanced technology pipeline of novel low development risk product candidates and longer-term major product opportunities. |
An Asia-Pacific based, ICH-GCP compliant CRO offering a complete range of Clinical Research and New Drug Development Services. |
Supplies components for genomic studies, and provides research, development and production services for clinical manufacturing. Includes details of products and technical resources. Headquarters in Liege, Belgium. |
A cutting edge, privately held company devoted to providing elegant and effective solutions to long standing human healthcare issues. |
A highly productive, intensely focused, quality-oriented CRO; experienced, well established, and driven by scientific merit. |
Drug discovery and development company that is focused on next generation anti-cancer drugs. |
Privately-held Australian drug discovery company with a focus on inflammatory diseases such as: Asthma, Rheumatoid Arthritis, Allergic Rhinitis (Hay fever), Food allergy, Inflammatory Bowel Disease, inter alia. Cytopia's first molecular targets are members of the JAK family of protein tyrosine kinases. |
Company focused on research and commercial developing of immune modulation therapies, for the treatment of cardiovascular, neurological, and other chronic inflammatory disorders. |
Development of proprietary, late stage pharmaceutical products that add market value and clinical benefit to existing drugs. |
Medical, pharmaceutical diagnostic projects using state-of-the-art pharmadiagnostic technologies. |
Characterizing and developing conventional and novel drug delivery systems. Describes staff, research projects, courses offered, and publications. Located in Jena, Germany. |
Core business is formulation development together with clinical trial material manufacturing and commercial manufacture of low volume products. |
A global leader in research, development and manufacturing of innovative ophthalmic pharmaceuticals that assist in the treatment diseases and disorders of the eye. |
Research company and institute dedicated to the discovery of novel drugs and therapeutics for diabetes, its complications, obesity, and related disorders. |
A South African biopharmaceutical discovery company that innovates therapeutic compounds in proprietary drug delivery systems, with cancer research as a primary focus. |
Develops and commercializes potentially improved versions of widely-prescribed drugs, designed to offer meaningful improvements in patient outcome through reduced side effects, increased efficacy, or improved dosage forms. (Nasdaq: SEPR). |
Originators of clinical saliva testing for female and male hormones. |
Researches and develops therapeutic products for the treatment of Cancer and Cancer related disorders. (Nasdaq: VION). |
Specializes in the drug discovering using GPCR targets and development focusing on oncology and anti-inflammatory drug discovery and development |
Neurotech Pharmaceuticals, founded in Apr.1998, aims to develop and invent Novel lead compounds that will threaten diseases associated with brain disorders and mal-functional retardances. |
Researching targeted therapies for cancer, neurodegenerative diseases, and neurofibromatosis. Find overviews, clinical trials and news. New York and California, USA. |
Chembiotek, a research company set up at Salt Lake, Kolkata offers state-of-the-art, creative technology to pharmaceutical, chemical and biotechnology industries. |
Indian pharmaceutical company manufacturing and marketing herbal products for psoriasis, vitiligo and any other skin aliments. |
Eli Lilly Ireland, specialising in women's health, depression and schizophrenia. |
Research into Optimised Human Health through Natural Nutriture, with minimal use of dietary supplements and natural medicines, if at all. Eradication of AIDS, Parasites, Cancer, Cardiovascular Disease, and premature aging. |
Jordan based pharmaceutical research center, offer services including clinical service, bioanalysis service, data management, quality assurance. |
A drug discovery company focusing its research on the discovery and pre-clinical phases of drug development. |
A biotechnology company dedicated to the discovery and development of diabetes mellitus treatment. Information on diabetes, type 2 diabetes, diabetes mellitus |
Drug design company focused on discovery and development of novel targeted medicines for the treatment of infectious diseases and cancer. |
A subsidiary of Bertin Group in the healthcare and life science division providing innovation and services in pharmaceutical development. |
Sapient Discovery - leading service provider of structure based drug design encompassing advanced bioinformatics, computational and X-ray crystallography. |
Provider of plasma-based products in the fields of regenerative medicine, oncology, and auto-immune diseases. |
A structure-based drug discovery company pioneering the use of High Throughput X-ray crystallography (HTX) for the rapid identification of novel drug candidates through structural screening-based in Cambridge, UK. |
An international pharmaceutical company, accelerating discovery and development of breakthrough drugs in HIV/AIDS and other therapeutic diseases. |
Research and development and production of new porphyrinic photosensitizers for photodynamic cancer therapy and other applications in collaboration with partners from institutes and universities throughout Europe. |
Develops an anti-obesity drug aimed at treating general obesity, preventing weight gain associated with anti-psychotic drug therapy, and improving lipid profiles. |
Research, diagnostics and pharmaceutical development related to nanobacterial infectious disease. |
Development and licencing out of novel presentations of off-patent generic pharmaceuticals and medical devices. Specialising in the fields of urology, intravenous fluids, woundcare and anaesthesia in plastic and flexible delivery systems. |
Virinova has developed a novel virus diagnostic technology for process control and diagnostic monitoring of viral infections. No antibodies or PCR is required and the method is suitable for all virus types including unknown viruses. It allows the direct detection of virus particles in minutes. |
UK company dedicated to the discovery of novel drug candidates in the anti-infective area. |
Company focus on developing molecular therapies for congestive heart failure through the application of scientific discoveries in molecular cardiology. |
Canadian company providing products and services in the research and development of pharmaceuticals, including the sale of research quantities of specialty chemicals and brokering of scale-up and custom synthesis contracts. |
Russian research Center aimed at creation of original medicinal preparations for prevention and treatment of cardiovascular, nervous and mental diseases and viral, bacterial and fungus infections. |
Site contains overview of new anti-infective technology developed by the company and problems of drug resistance in general. Bacterial Transforming Agents change antibiotic-resistant bacteria, e.g. MRSA, into antibiotic-susceptible bacteria. |
Provides development and support services to pharmaceutical firms and contract research organizations. |
Develops and markets innovative products to guide and improve treatment of viral diseases. (Nasdaq: MGRM). |
Global company aiming to maximize developments and discoveries of academic research into breakthrough treatments for human disease. |
| Help build the largest human-edited directory on the web. |
| Submit a Site - Open Directory Project - Become an Editor |
Domain Tools analysis of DMOZ top listed domains
